Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypoxic Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06939270
What this trial is testing

CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Chinese PLA General Hospital 30
Not applicableStudy completedNCT01248637
What this trial is testing

Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto 200
Not applicableEnded earlyNCT01881451
What this trial is testing

Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian Neoplasms
British Columbia Cancer Agency 5
Not applicableStudy completedNCT06027021
What this trial is testing

Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Who this might be right for
RadioembolizationRadiotherapyCancer+1 more
Ankara University 64
Early research (Phase 1)Study completedNCT02564614
What this trial is testing

Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 9
Not applicableNot Yet RecruitingNCT07670455
What this trial is testing

Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response

Who this might be right for
High Grade GliomasHypoxia BrainGlioblastoma (GBM)+1 more
The Leeds Teaching Hospitals NHS Trust 25
Testing effectiveness (Phase 2)Temporarily pausedNCT03181035
What this trial is testing

Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer

Who this might be right for
Tongue Cancer
Sunnybrook Health Sciences Centre 10
Not applicableStudy completedNCT02624115
What this trial is testing

FAZA PET as Biomarker for Hypoxia in Rectal Cancer

Who this might be right for
Colon Rectal Cancer Adenocarcinoma
University Health Network, Toronto 8
Not applicableStudy completedNCT00188708
What this trial is testing

Effect of Casodex on Tumour Hypoxia - Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 30
Not applicableUnknownNCT03319017
What this trial is testing

Apoptosis in Polymorphonuclear Cells and Inflammatory Cytokines of Trauma Patients

Who this might be right for
Trauma
Korea University Guro Hospital 100
Early research (Phase 1)Ended earlyNCT03573986
What this trial is testing

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Who this might be right for
Recurrent Glioblastoma
Abramson Cancer Center at Penn Medicine 2
Early research (Phase 1)Study completedNCT00003282
What this trial is testing

EF5 in Treating Patients With Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 50
Early research (Phase 1)Looking for participantsNCT06834126
What this trial is testing

Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

Who this might be right for
Locally Advanced Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8
City of Hope Medical Center 36
Testing effectiveness (Phase 2)Ended earlyNCT05119335
What this trial is testing

NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+14 more
NiKang Therapeutics, Inc. 120
Not applicableStudy completedNCT00180180
What this trial is testing

Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Who this might be right for
Head and Neck Neoplasms
Technische Universität Dresden 60
Not applicableWithdrawnNCT00638040
What this trial is testing

The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression

Who this might be right for
HypoxiaLactic Acidosis
Duke University
Not applicableLooking for participantsNCT03797482
What this trial is testing

A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer

Who this might be right for
Breast Cancer Female
Tata Memorial Hospital 500
Not applicableStudy completedNCT02323464
What this trial is testing

Prevalence of Sleep Apnea in Patients Undergoing Surgery for Colorectal Cancer

Who this might be right for
Colorectal CancerSleep Apnea SyndromesHypoxia
Karl A Franklin 212
Not applicableWithdrawnNCT02496832
What this trial is testing

Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo

Who this might be right for
Pancreatic AdenocarcinomaAdvanced DiseaseMetastatic Disease
University Health Network, Toronto
Early research (Phase 1)WithdrawnNCT02598687
What this trial is testing

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Maastricht Radiation Oncology
Next Page